316 related articles for article (PubMed ID: 29342343)
1. Redox Sensitive Shell and Core Crosslinked Hyaluronic Acid Nanocarriers for Tumor-Targeted Drug Delivery.
Zheng H; Yin L; Zhang X; Zhang H; Hu R; Yin Y; Qiu T; Xiong X; Wang Q
J Biomed Nanotechnol; 2016 Aug; 12(8):1641-53. PubMed ID: 29342343
[TBL] [Abstract][Full Text] [Related]
2. Endogenous inspired biomineral-installed hyaluronan nanoparticles as pH-responsive carrier of methotrexate for rheumatoid arthritis.
Alam MM; Han HS; Sung S; Kang JH; Sa KH; Al Faruque H; Hong J; Nam EJ; Kim IS; Park JH; Kang YM
J Control Release; 2017 Apr; 252():62-72. PubMed ID: 28288894
[TBL] [Abstract][Full Text] [Related]
3. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
4. pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate.
Gao C; Liu T; Dang Y; Yu Z; Wang W; Guo J; Zhang X; He G; Zheng H; Yin Y; Kong X
Carbohydr Polym; 2014 Oct; 111():964-70. PubMed ID: 25037437
[TBL] [Abstract][Full Text] [Related]
5. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.
Han HS; Thambi T; Choi KY; Son S; Ko H; Lee MC; Jo DG; Chae YS; Kang YM; Lee JY; Park JH
Biomacromolecules; 2015 Feb; 16(2):447-56. PubMed ID: 25565417
[TBL] [Abstract][Full Text] [Related]
6. Enzymatically Disulfide-Crosslinked Chitosan/Hyaluronic Acid Layer-by-Layer Self-Assembled Microcapsules for Redox-Responsive Controlled Release of Protein.
Yang Y; Zhu H; Wang J; Fang Q; Peng Z
ACS Appl Mater Interfaces; 2018 Oct; 10(39):33493-33506. PubMed ID: 30203959
[TBL] [Abstract][Full Text] [Related]
7. Triggered doxorubicin release using redox-sensitive hyaluronic acid-g-stearic acid micelles for targeted cancer therapy.
Jeong GW; Jeong YI; Nah JW
Carbohydr Polym; 2019 Apr; 209():161-171. PubMed ID: 30732795
[TBL] [Abstract][Full Text] [Related]
8. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
9. In vitro control release, cytotoxicity assessment and cellular uptake of methotrexate loaded liquid-crystalline folate nanocarrier.
Misra R; Upadhyay M; Perumal V; Mohanty S
Biomed Pharmacother; 2015 Feb; 69():102-10. PubMed ID: 25661345
[TBL] [Abstract][Full Text] [Related]
10. Bioreducible core-crosslinked hyaluronic acid micelle for targeted cancer therapy.
Han HS; Choi KY; Ko H; Jeon J; Saravanakumar G; Suh YD; Lee DS; Park JH
J Control Release; 2015 Feb; 200():158-66. PubMed ID: 25550153
[TBL] [Abstract][Full Text] [Related]
11. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M
J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595
[TBL] [Abstract][Full Text] [Related]
12. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.
Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH
Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360
[TBL] [Abstract][Full Text] [Related]
13. Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery.
Yoon HY; Koo H; Choi KY; Chan Kwon I; Choi K; Park JH; Kim K
Biomaterials; 2013 Jul; 34(21):5273-80. PubMed ID: 23591396
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of quercetin-loaded hyaluronic acid-conjugated pH/redox dual-stimuli responsive poly(methacrylic acid)/mesoporous organosilica nanoparticles for breast cancer targeted therapy.
Ghalehkhondabi V; Soleymani M; Fazlali A
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130168. PubMed ID: 38365162
[TBL] [Abstract][Full Text] [Related]
16. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
[TBL] [Abstract][Full Text] [Related]
17. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
[TBL] [Abstract][Full Text] [Related]
18. Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions.
Wu L; Zou Y; Deng C; Cheng R; Meng F; Zhong Z
Biomaterials; 2013 Jul; 34(21):5262-72. PubMed ID: 23570719
[TBL] [Abstract][Full Text] [Related]
19. pH and redox dual responsive carrier-free anticancer drug nanoparticles for targeted delivery and synergistic therapy.
Zhou M; Wei W; Chen X; Xu X; Zhang X; Zhang X
Nanomedicine; 2019 Aug; 20():102008. PubMed ID: 31121311
[TBL] [Abstract][Full Text] [Related]
20. Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel.
Li J; Yin T; Wang L; Yin L; Zhou J; Huo M
Int J Pharm; 2015 Apr; 483(1-2):38-48. PubMed ID: 25655715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
